These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 24419083)

  • 1. Design of a novel integration-deficient lentivector technology that incorporates genetic and posttranslational elements to target human dendritic cells.
    Tareen SU; Kelley-Clarke B; Nicolai CJ; Cassiano LA; Nelson LT; Slough MM; Vin CD; Odegard JM; Sloan DD; Van Hoeven N; Allen JM; Dubensky TW; Robbins SH
    Mol Ther; 2014 Mar; 22(3):575-587. PubMed ID: 24419083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Virological and preclinical characterization of a dendritic cell targeting, integration-deficient lentiviral vector for cancer immunotherapy.
    Odegard JM; Kelley-Clarke B; Tareen SU; Campbell DJ; Flynn PA; Nicolai CJ; Slough MM; Vin CD; McGowan PJ; Nelson LT; Ter Meulen J; Dubensky TW; Robbins SH
    J Immunother; 2015; 38(2):41-53. PubMed ID: 25658613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrase-defective lentiviral vectors encoding cytokines induce differentiation of human dendritic cells and stimulate multivalent immune responses in vitro and in vivo.
    Daenthanasanmak A; Salguero G; Borchers S; Figueiredo C; Jacobs R; Sundarasetty BS; Schneider A; Schambach A; Eiz-Vesper B; Blasczyk R; Weissinger EM; Ganser A; Stripecke R
    Vaccine; 2012 Jul; 30(34):5118-31. PubMed ID: 22691433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Construction of stable producer cells to make high-titer lentiviral vectors for dendritic cell-based vaccination.
    Lee CL; Chou M; Dai B; Xiao L; Wang P
    Biotechnol Bioeng; 2012 Jun; 109(6):1551-60. PubMed ID: 22179950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Engineered lentivector targeting of dendritic cells for in vivo immunization.
    Yang L; Yang H; Rideout K; Cho T; Joo KI; Ziegler L; Elliot A; Walls A; Yu D; Baltimore D; Wang P
    Nat Biotechnol; 2008 Mar; 26(3):326-34. PubMed ID: 18297056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transduction of dendritic cells by antigen-encoding lentiviral vectors permits antigen processing and MHC class I-dependent presentation.
    Zarei S; Leuba F; Arrighi JF; Hauser C; Piguet V
    J Allergy Clin Immunol; 2002 Jun; 109(6):988-94. PubMed ID: 12063529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lentiviral Protein Transfer Vectors Are an Efficient Vaccine Platform and Induce a Strong Antigen-Specific Cytotoxic T Cell Response.
    Uhlig KM; Schülke S; Scheuplein VA; Malczyk AH; Reusch J; Kugelmann S; Muth A; Koch V; Hutzler S; Bodmer BS; Schambach A; Buchholz CJ; Waibler Z; Scheurer S; Mühlebach MD
    J Virol; 2015 Sep; 89(17):9044-60. PubMed ID: 26085166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a replication-competent lentivirus assay for dendritic cell-targeting lentiviral vectors.
    Farley DC; McCloskey L; Thorne BA; Tareen SU; Nicolai CJ; Campbell DJ; Bannister R; Stewart HJ; Pearson LJ; Moyer BJ; Robbins SH; Zielinski L; Kim T; Radcliffe PA; Mitrophanous KA; Gombotz WR; Miskin JE; Kelley-Clarke B
    Mol Ther Methods Clin Dev; 2015; 2():15017. PubMed ID: 26029728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel dendritic cell-targeted lentiviral vector, encoding Ag85A-ESAT6 fusion gene of Mycobacterium tuberculosis, could elicit potent cell-mediated immune responses in mice.
    Shakouri M; Moazzeni SM; Ghanei M; Arashkia A; Etemadzadeh MH; Azadmanesh K
    Mol Immunol; 2016 Jul; 75():101-11. PubMed ID: 27267270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Redirecting lentiviral vectors pseudotyped with Sindbis virus-derived envelope proteins to DC-SIGN by modification of N-linked glycans of envelope proteins.
    Morizono K; Ku A; Xie Y; Harui A; Kung SK; Roth MD; Lee B; Chen IS
    J Virol; 2010 Jul; 84(14):6923-34. PubMed ID: 20484510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measles virus glycoprotein-pseudotyped lentiviral vectors are highly superior to vesicular stomatitis virus G pseudotypes for genetic modification of monocyte-derived dendritic cells.
    Humbert JM; Frecha C; Amirache Bouafia F; N'Guyen TH; Boni S; Cosset FL; Verhoeyen E; Halary F
    J Virol; 2012 May; 86(9):5192-203. PubMed ID: 22345444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lentivirus-transduced human monocyte-derived dendritic cells efficiently stimulate antigen-specific cytotoxic T lymphocytes.
    Dyall J; Latouche JB; Schnell S; Sadelain M
    Blood; 2001 Jan; 97(1):114-21. PubMed ID: 11133750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell type-specific targeting with sindbis pseudotyped lentiviral vectors displaying anti-CCR5 single-chain antibodies.
    Aires da Silva F; Costa MJ; Corte-Real S; Goncalves J
    Hum Gene Ther; 2005 Feb; 16(2):223-34. PubMed ID: 15761262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficient gene transfer to human peripheral blood monocyte-derived dendritic cells using human immunodeficiency virus type 1-based lentiviral vectors.
    Chinnasamy N; Chinnasamy D; Toso JF; Lapointe R; Candotti F; Morgan RA; Hwu P
    Hum Gene Ther; 2000 Sep; 11(13):1901-9. PubMed ID: 10986562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preconditioning therapy with lentiviral vector-programmed dendritic cells accelerates the homeostatic expansion of antigen-reactive human T cells in NOD.Rag1-/-.IL-2rγc-/- mice.
    Salguero G; Sundarasetty BS; Borchers S; Wedekind D; Eiz-Vesper B; Velaga S; Jirmo AC; Behrens G; Warnecke G; Knöfel AK; Blasczyk R; Mischak-Weissinger E; Ganser A; Stripecke R
    Hum Gene Ther; 2011 Oct; 22(10):1209-24. PubMed ID: 21574869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo administration of a lentiviral vaccine targets DCs and induces efficient CD8(+) T cell responses.
    Esslinger C; Chapatte L; Finke D; Miconnet I; Guillaume P; Lévy F; MacDonald HR
    J Clin Invest; 2003 Jun; 111(11):1673-81. PubMed ID: 12782670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccines delivered by integration-deficient lentiviral vectors targeting dendritic cells induces strong antigen-specific immunity.
    Hu B; Dai B; Wang P
    Vaccine; 2010 Sep; 28(41):6675-83. PubMed ID: 20709004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dendritic cell-directed lentivector vaccine induces antigen-specific immune responses against murine melanoma.
    Yang HG; Hu BL; Xiao L; Wang P
    Cancer Gene Ther; 2011 May; 18(5):370-80. PubMed ID: 21372855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunity of lentiviral vector-modified dendritic cells.
    Han S; Chang LJ
    Methods Mol Biol; 2009; 542():245-59. PubMed ID: 19565906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV-1 Gag-specific immunity induced by a lentivector-based vaccine directed to dendritic cells.
    Dai B; Yang L; Yang H; Hu B; Baltimore D; Wang P
    Proc Natl Acad Sci U S A; 2009 Dec; 106(48):20382-7. PubMed ID: 19918062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.